Company India Globalization Capital, Inc. Nyse
Equities
US45408X3089
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.522 USD | -61.62% | -47.69% | +36.00% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life Sciences
87.6
%
| 0 | 90.7 % | 1 | 87.6 % | +122.28% |
Infrastructure
12.4
%
| 0 | 9.3 % | 0 | 12.4 % | +205.41% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
85.3
%
| 0 | 82.9 % | 1 | 85.3 % | +136.17% |
India
12.4
%
| 0 | 17.1 % | 0 | 12.4 % | +66.18% |
Colombia
2.3
%
| - | - | 0 | 2.3 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 18-05-08 |
Chief Tech/Sci/R&D Officer | - | - | |
Jagadeesh Rao
CTO | Chief Tech/Sci/R&D Officer | 57 | 17-09-30 |
Rohit Goel
AUD | Comptroller/Controller/Auditor | 30 | 17-09-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 05-04-28 |
Richard Prins
CHM | Chairman | 67 | 07-04-30 |
Director/Board Member | 79 | 22-01-17 | |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 18-05-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 66,541,532 | 52,940,787 ( 79.56 %) | 0 | 79.56 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+26.25% | 44.96B | |
-0.83% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.50% | 26.08B | |
-21.22% | 19.03B | |
+5.87% | 12.75B | |
+28.46% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- IGC Stock
- Stock
- Company India Globalization Capital, Inc.